Powerful News

Powerful Mission

MMRF Press Releases

MMRF In The News

MMRF Newsletters

MMRF Social Networking

MMRF Media Room

Financial Reports

Employment Opportunities

Powerful News

2010

07/29/10 — The Multiple Myeloma Research Foundation (MMRF) Names Walter Capone Chief Operating Officer...

07/28/10 — Multiple Myeloma Research Consortium (MMRC) Plays Critical Role in Advancing Carfilzomib...

07/26/10 — Onyx Pharmaceuticals Announces Positive Top-Line Carfilzomib Data from Phase 2b Study...

07/17/10 — Music Legends Headline Multiple Myeloma Research Foundation's 14th Annual Fall Gala...

06/01/10 — Eighth Annual Multiple Myeloma Research Foundation (MMRF) Laugh for Life: New York Raises Over $570,000 to Accelerate Development of New Treatments for Multiple Myeloma...

06/01/10 — Multiple Myeloma Research Consortium (MMRC) Announces Data Presentations at 46th Annual American Society of Clinical Oncology (ASCO) Annual Meeting...

05/17/10 — Multiple Myeloma Research Foundation (MMRF) to Celebrate Eighth Annual MMRF Laugh for Life: New York...

05/13/10 — Multiple Myeloma Research Foundation (MMRF) Has Community, National Impact...

04/29/10 — 9th Annual Multiple Myeloma Research Foundation Chicago Awards Dinner Raises $950,000 to Accelerate Development of New Cancer Treatments...

04/20/10 — Multiple Myeloma Research Consortium (MMRC) Genomics Initiative Provides First In-depth Look at Multiple Myeloma Genome...

04/06/10 — Multiple Myeloma Research Consortium (MMRC) Initiates Phase IB/II Clinical Trial of Treanda® in Combination with Revlimid® and Dexamethasone in Patients with Relapsed Multiple Myeloma...

03/29/10 — Multiple Myeloma Research Foundation (MMRF) Grants $1.0 Million Each to Intellikine, Inc. and Tragara Pharmaceuticals, Inc. to Advance Next-Generation Therapies for Multiple Myeloma...

03/29/10 — MannKind Corporation Achieves All Milestones of Research Agreement with Multiple Myeloma Research Foundation to Develop New Therapy...

03/26/10 — Multiple Myeloma Research Foundation (MMRF) Welcomes MasterCard President Chris McWilton to Board of Directors...

02/17/10 — Multiple Myeloma Research Foundation (MMRF) Receives Highest Rating from Charity Navigator for Exceptional Fiscal Management...

2009

12/30/09 — Multipole Myeloma Research Foundation (MMRF) and Multiple Myeloma Research Consortium (MMRC) Mourns Loss of Frederick Joseph...

12/04/09 — Multiple Myeloma Research Consortium (MMRC) Honors Dana-Farber Cancer Institute with 2009 Center of the Year Award...

11/23/09 — Multiple Myeloma Research Consortium (MMRC) Unveils 16 Abstracts at Ash...

11/11/09 — Multiple Myeloma Research Foundation (MMRF) Names Robert Lucas Vice President of Development...

10/27/09 — Multiple Myeloma Research Foundation's (MMRF) Fall Gala Raises More Than $1.8 Million to Advance Cancer Research...

10/19/09 — Harvard Business School Awards MMRF Founder, CEO with Alumni Achievement Award...

09/14/09 — Sports Legends and Broadcast Personalities Headline Multiple Myeloma Research Foundation's 13TH Annual Fall Gala...

08/03/09 — Hoda Kotb and Boomer Esiason to join Multiple Myeloma Research Foundation (MMRF) at 13th Annual Fall Gala...

07/27/09 — MMRC Multiple Myeloma Genomics Initiative First to Sequence Complete Myeloma Genomes ...

06/18/09 — Multiple Myeloma Research Consortium (MMRC) Activates Clinical Trials 30-40 Percent Faster Than Industry Standard...

05/18/09 — Cancer Research Partnership Between UCSF, MMRF to Drive Drug Development...

05/18/09 — MMRF and the Broad Institute of MIT and Harvard Announce Collaboration to Perform Whole Genome Sequencing of Multiple Myeloma Samples...

04/14/09 — AACR Awards Centennial Medals for Distinguished Public Service...

03/02/09 — Multiple Myeloma Research Foundation (MMRF) Grants $1.0 Million to Aileron Therapeutics and Astex Therapeutics to Advance New Therapies for Multiple Myeloma...

02/16/09 — The Multiple Myeloma Research Foundation (MMRF) and Leukemia & Lymphoma Society (LLS) Partner to Fund $500,000 in Cancer Stem Cell Research Grants...

01/16/09 — Multiple Myeloma Research Consortium (MMRC) and Merck initiate Phase II Trial of Zolinza with Velcade in Relapsed and Refractory Multiple Myeloma Patients...

View Older Press Releases

Powered by Convio

nonprofit software